Open Access
Thorac Cardiovasc Surg 2017; 65(S 01): S1-S110
DOI: 10.1055/s-0037-1598742
Oral Presentations
Sunday, February 12, 2017
DGTHG: Basic Science: Myocardial Regeneration
Georg Thieme Verlag KG Stuttgart · New York

Implantation of Spontaneously Beating Human iPS Cell-Derived ENGINEERED HEART TISSUE Does Not Provoke Ventricular Arrhythmias in a Guinea Pig Infarction Model

S. Pecha
1   Universitäres Herzzentrum Hamburg, Herz und Gefäßchirurgie, Hamburg, Germany
,
K. Breckwoldt
2   Universitätsklinikum Hamburg-Eppendorf, Experimentelle Pharmakologie und Toxikologie, Hamburg, Germany
,
M. Roehl
3   Universitätsklinikum Hamburg-Eppendorf, Zelluläre und integrative Physiologie, Hamburg, Germany
,
B. Geertz
2   Universitätsklinikum Hamburg-Eppendorf, Experimentelle Pharmakologie und Toxikologie, Hamburg, Germany
,
F. Weinberger
4   Universitäres Herzzentrum Hamburg, Kinderkardiologie, Hamburg, Germany
,
A. Hansen
2   Universitätsklinikum Hamburg-Eppendorf, Experimentelle Pharmakologie und Toxikologie, Hamburg, Germany
,
A. Schwoerer
3   Universitätsklinikum Hamburg-Eppendorf, Zelluläre und integrative Physiologie, Hamburg, Germany
,
H. Reichenspurner
1   Universitäres Herzzentrum Hamburg, Herz und Gefäßchirurgie, Hamburg, Germany
,
T. Eschenhagen
2   Universitätsklinikum Hamburg-Eppendorf, Experimentelle Pharmakologie und Toxikologie, Hamburg, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
03 February 2017 (online)

 

    Objectives: Engineered heart tissue (EHT) is an in vitro generated three-dimensional, force generating cardiomyocyte network with morphological and functional properties of native myocardium. Incomplete coupling or spontaneous electrical activity of EHTs might provoke ventricular arrhythmias (VA) when transplanted onto a recipient's heart. The aim of this study was to investigate the occurrence of ventricular arrhythmias after implantation of human induced pluripotent stem cell (hiPSC)-derived EHT in a guinea pig infarction model.

    Methods: Human iPSC were generated by retroviral reprogramming of dermal fibroblasts. Cardiac differentiation of hiPSC was performed by an embryoid body-based three-stage differentiation protocol. EHTs were created from hiPS-CM (5 × 106 cardiomyocytes and 2 × 106 hiPSC-endothelial cells per EHT). Left ventricular myocardial cryo-injury was induced in adult guinea pigs (n = 18) and telemetry sensors were implanted in all animals for continuous ECG monitoring. 7 days after cryo-injury, EHTs (Group I; 2 EHTs per animal, n = 10) or cell-free constructs (Group II; n = 8) were implanted.

    Results: Cryo-injury resulted in large histologically verified transmural infarctions of the left ventricular wall. Dystrophin and MLC2V positive cross-striated muscle tissue was observed in the scar area of EHT transplanted animals. The human origin was demonstrated by staining for human Ku80, a human-specific marker. After induction of cryo-injury and before implantation of EHT or cell free constructs (7days), non-sustained or sustained ventricular arrhythmias were observed in 0 and 2 (33.3%) animals of Group I and II, respectively. After implantation of EHTs no sustained ventricular tachycardias were seen in any of the animals. However, 58 couplets, 15 triplets and 26 non-sustained ventricular tachycardias (NSVT) were observed in 5 animals (50%) during 28 days of follow-up. In the control group no VTs, but 9 NSVTs, 42 couplets and 15 triplets occurred in 6 (75%) animals during the same period of time. The incidence of VTs or NSVTs did not differ significantly between the two groups (Group I: 2.6, Group II: 1.2 ventricular arrhythmias per animal; p = 0.39).

    Conclusion: Transplantation of hiPSC-derived EHTs in a guinea pig cryo-injury model generates new myocardium. Our telemetric data showed overall a low rate of arrhythmias in this model and provide no evidence for hiPSC-derived EHTs to induce ventricular arrhythmias.


    No conflict of interest has been declared by the author(s).